Brookdale Senior Living Inc. (BKD) P/E Ratio History
Historical price-to-earnings valuation from 2020 to 2020
Loading P/E history...
Valuation Context
How does the current P/E compare to historical and market benchmarks?
P/E Ratio Analysis
As of February 28, 2026, Brookdale Senior Living Inc. (BKD) trades at a price-to-earnings ratio of -13.7x, with a stock price of $15.30 and trailing twelve-month earnings per share of $-1.12.
The current P/E is 256% below its 5-year average of 8.8x. Over the past five years, BKD's P/E has ranged from a low of 3.9x to a high of 14.1x, placing the current valuation at the 0th percentile of its historical range.
Compared to the Healthcare sector median P/E of 23.7x, BKD trades at a 158% discount to its sector peers. The sector includes 224 companies with P/E ratios ranging from 0.0x to 184.4x.
Relative to the broader market, BKD trades at a notable discount to the S&P 500 median P/E of 26.2x. Investors should consider the company's growth prospects, competitive position, and earnings quality when evaluating whether the current valuation is justified.
For a comprehensive intrinsic value estimate using discounted cash flow analysis, see our BKD DCF Valuation Calculator →
Note: P/E ratio is just one valuation metric. It does not account for balance sheet strength, cash flow quality, or growth sustainability. Always conduct comprehensive due diligence before making investment decisions.
Peer Comparison
P/E metrics vs. Post-acute and senior care peers
| Company | Market Cap | P/E Ratio | PEG Ratio | EPS Growth (1Y) |
|---|---|---|---|---|
ENSGThe Ensign Group, Inc. | $12B | 36.7 | 2.66 | +14% |
EHCEncompass Health Corporation | $11B | 19.4 | 1.36 | +24%Best |
NHCNational HealthCare Corporation | $3B | 21.3 | 0.93Best | +17% |
SEMSelect Medical Holdings Corporation | $2B | 12.9Lowest | - | -30% |
PNTGThe Pennant Group, Inc. | $1B | 40.1 | 3.99 | +18% |
Peers sorted by market capitalization. P/E below peers may indicate undervaluation or lower growth expectations. Consider PEG ratio for growth-adjusted comparison.
Historical P/E Data
Quarterly P/E ratios calculated from closing price and TTM EPS
| Quarter | Date | Price | TTM EPS | P/E Ratio | vs Avg |
|---|---|---|---|---|---|
| FY2020 Q4 | $4.43 | $0.43 | 10.3x | +18% | |
| FY2020 Q3 | Wed Sep 30 2020 00:00:00 GM | $2.54 | $0.18 | 14.1x | +61% |
| FY2020 Q2 | $2.95 | $0.44 | 6.7x | -24% | |
| FY2020 Q1 | $3.12 | $0.79 | 3.9x | -55% |
Average P/E for displayed period: 8.8x
See BKD's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs BKD Undervalued?
See our Bear / Base / Bull DCF models and intrinsic value estimates.
View ValuationCompare BKD vs AGIO
See how BKD stacks up against sector leader Agios Pharmaceuticals, Inc..
Start ComparisonFrequently Asked Questions
Is BKD stock overvalued or undervalued?
BKD trades at -13.7x P/E, below its 5-year average of 8.8x. At the N/A percentile of historical range, the stock is priced at a discount to its own history.
How does BKD's valuation compare to peers?
Brookdale Senior Living Inc. P/E of -13.7x compares to sector median of 23.7x. The discount suggests lower growth expectations or higher risk.
What is BKD's PEG ratio?
BKD PEG ratio is N/A. Above 2.0 indicates premium valuation relative to growth rate. Historical P/E data spans 2020-2020.